Goldman Sachs Group Inc Seres Therapeutics, Inc. Put Options Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
Put Options
2 transactions
Others Institutions Holding MCRB
# of Institutions
38Shares Held
29MCall Options Held
103KPut Options Held
53K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$357 Million6.86% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$27.2 Million0.0% of portfolio
-
Lion Point Capital, LP New York, NY341KShares$5.26 Million2.45% of portfolio
-
Tang Capital Management LLC San Diego, CA204KShares$3.15 Million0.01% of portfolio
-
Morgan Stanley New York, NY150KShares$2.31 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.92B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...